Latest Articles

Publication Date
N6-methyladenosine regulated FZD7 inhibits ferroptosis in endometriosis via β-catenin/SLC7A11 pathway.

Endometriosis (EMS), a chronic inflammatory disease affecting approximately 10% reproductive aged women, remains etiologically unclear. This study aims to investigate the role and underlying mechanisms of frizzled class receptor 7 …

Published: Nov. 13, 2025, midnight
Long noncoding RNAs and microRNAs in Endometriosis.

Endometriosis represents a prevalent gynaecological disorder, impacting around 10% of the female population and affecting as many as 50% of women who are facing challenges with infertility. The pathogenesis of …

Published: Nov. 13, 2025, midnight
Herlyn-Werner-Wunderlich (HWW) Syndrome in an Adolescent.

Herlyn-Werner-Wunderlich (HWW) syndrome, also known as obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome, is a rare Müllerian duct anomaly characterized by the triad of uterus didelphys, obstructed hemivagina, and …

Published: Nov. 13, 2025, midnight
Amy Schumer Explains Instagram Swipe: “My Focus Has Been on Health” - The Hollywood Reporter

Amy Schumer Explains Instagram Swipe: “My Focus Has Been on Health” The Hollywood Reporter

Published: Nov. 12, 2025, 11:48 p.m.
Amy Schumer Explains Instagram Swipe: “My Focus Has Been on Health” - IMDb

Amy Schumer Explains Instagram Swipe: “My Focus Has Been on Health” IMDb

Published: Nov. 12, 2025, 11:48 p.m.
Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results - The Manila Times

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results The Manila Times

Published: Nov. 12, 2025, 9:29 p.m.
Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results - GlobeNewswire

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results GlobeNewswire

Published: Nov. 12, 2025, 9:05 p.m.
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork

Published: Nov. 12, 2025, 7:12 p.m.
FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma Targeted Oncology

Published: Nov. 12, 2025, 7:08 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!